Get to market, wherever your market is.
Regulatory strategy and market access support across the FDA, EU MDR and UK pathways — from initial classification through to submission, conformity assessment and post-market obligations.
Choose your pathway.
Each jurisdiction has its own route, its own vocabulary and its own evidence expectations. We work across all three, with engineering and regulatory specialists in the same delivery team.
FDA market access
Classification, 510(k) clearance and De Novo authorization strategy, Pre-Submission meetings and FDA correspondence support.
Explore →CE marking under EU MDR
Software classification, CE marking strategy, conformity assessment planning and Notified Body preparation.
Explore →UK market access
UK medical device requirements, MHRA registration where applicable and preparation for the evolving UK framework.
Explore →Not sure which route applies?
We'll help you establish qualification, classification and the sequencing that gets your product to market with the least avoidable risk.
